Izumiya, Yasuhiro <br/><br/>
Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris.  [electronic resource] 

 -  Atherosclerosis  Feb 2011 
 - 415-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1484 
<br/><br/><label>Standard No.: </label>10.1016/j.atherosclerosis.2010.11.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Angina Pectoris--diagnostic imaging<br/>Animals<br/>Aortic Diseases--genetics<br/>Apolipoproteins E--deficiency<br/>Atherosclerosis--genetics<br/>Cardiovascular Agents--administration & dosage<br/>Cells, Cultured<br/>Chi-Square Distribution<br/>Coronary Artery Disease--complications<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Drug Administration Schedule<br/>Endoplasmic Reticulum--drug effects<br/>Endoplasmic Reticulum Chaperone BiP<br/>Endothelial Cells--drug effects<br/>Fibrosis<br/>Humans<br/>Inflammation Mediators--metabolism<br/>Japan<br/>Lipids--blood<br/>Logistic Models<br/>Macrophages--drug effects<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Middle Aged<br/>Molecular Chaperones--metabolism<br/>Necrosis<br/>Nicorandil--administration & dosage<br/>Odds Ratio<br/>Retrospective Studies<br/>Time Factors<br/>Treatment Outcome<br/>Ultrasonography, Interventional